111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Lower downside than CX's downside of 16.39%.
Buy
Better than CX's analyst recommendation of Hold.
Analyze analyst forecasts for the company and compare them with competitors.
25.20B
Better than CX's estimated revenue of 14.36B.
4.15B
Better than CX's estimated ebitda of 2.52B.
1.04
Better than CX's estimated eps of -1.81.
756.43M
Worse than CX's estimated net income of 10.34B.
2.75B
Better than CX's estimated ebit of 1.42B.
5.65B
Worse than CX's estimated sg&a expense of 2.66B.
Analyze DCF forecasts for the company and compare them with competitors.
50.61B
Better than CX's revenue of 1.15B.
8.68%
Better than CX's revenue growth rate of 7.41%.
7.97B
Better than CX's ebitda of 166.39M.
15.75%
Better than CX's ebitda margin of 14.52%.
5.16B
Better than CX's ebit of 78.17M.
10.19%
Better than CX's ebit margin of 6.82%.
2.81B
Worse than CX's depreciation of 88.23M.
11.96B
Better than CX's total cash of 55.71M.
23.64%
Better than CX's cash as percentage of revenue of 4.86%.
3.92B
Worse than CX's receivables of 129.42M.
7.75%
Better than CX's receivables as percentage of revenue of 11.29%.
5.97B
Worse than CX's inventories of 102.42M.
11.80%
Worse than CX's inventories as percentage of revenue of 8.94%.
4.16B
Worse than CX's accounts payable of 217.65M.
8.23%
Better than CX's payables as percentage of revenue of 18.99%.
-2.36B
Better than CX's capital expenditure of -70.56M.
-4.66%
Worse than CX's capex as percentage of revenue of -6.16%.
9.65%
Worse than CX's weighted average cost of capital (wacc) of 9.43%.
10.90%
Worse than CX's cost of equity of 9.69%.
4.40%
Better than CX's cost of debt of 7.04%.
1.38
Worse than CX's beta of 1.12.
729.20M
Better than CX's diluted shares outstanding of 1.47B.
13.52B
Worse than CX's total debt of 404.20M.
68.33B
Better than CX's total equity of 8.15B.
81.85B
Better than CX's total capital of 8.55B.
16.51%
Worse than CX's debt weighting of 4.73%.
83.49%
Worse than CX's equity weighting of 95.27%.
3.89B
Better than CX's ebiat of 47.24M.
3.89B
Better than CX's unlevered free cash flow of 63.93M.
2.00%
Equal to CX's long-term growth rate of 2.00%.
56.34B
Better than CX's terminal value of 942.19M.
50.72B
Better than CX's enterprise value of 837.22M.
6.94B
Worse than CX's net debt of 373.30M.
43.78B
Better than CX's equity value of 463.91M.
60.04
Better than CX's equity value per share of 0.32.
